Levinthal Biotech
力文所
Levinthal Biotech is a Hangzhou-based biotech startup developing a self-developed all-atom model called Pallatom, which was included on NVIDIA's recommended list . The company was founded in 2021 and received seed funding from ZhenFund that year, with the fund continuing to back it through its angel round . In late 2025, Levinthal completed a tens-of-millions-of-yuan Pre-A round led by Jolmo Investment Management, with Junke Danmu participating and Zhoudu Capital serving as exclusive financial advisor . elsewise's corpus does not cover the company's full pipeline or team beyond these financing and technology milestones.
AI-generated — may contain errors, please verify.
Coverage
ZhenFund angel project "Livinova" completes tens of millions of yuan in Pre-A funding; self-developed all-atom model Pallatom makes NVIDIA's recommended list
The new funding will accelerate iterative upgrades to Pallatom, its full-atom model protein design platform, expand its commercial pipeline, and support global talent recruitment.
Venture Where No One Has Gone Before | Z News
July is drawing to a close, and we invite you to join us in witnessing the growth of our portfolio companies and what's new at ZhenFund.
Late Summer Sun, Breezes Bringing Autumn | Z News
A gentle breeze blows warm and pleasant.
